(R)-4-ethyl-9-(2-fluorophenethyl)-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one

ID: ALA4776924

PubChem CID: 118560963

Max Phase: Preclinical

Molecular Formula: C19H27FN2O2

Molecular Weight: 334.44

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCN1CC2(CCN(CCc3ccccc3F)CC2)O[C@H](C)C1=O

Standard InChI:  InChI=1S/C19H27FN2O2/c1-3-22-14-19(24-15(2)18(22)23)9-12-21(13-10-19)11-8-16-6-4-5-7-17(16)20/h4-7,15H,3,8-14H2,1-2H3/t15-/m1/s1

Standard InChI Key:  LYZONYJDSRWDIH-OAHLLOKOSA-N

Molfile:  

 
     RDKit          2D

 24 26  0  0  0  0  0  0  0  0999 V2000
   25.5063  -18.7789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5021  -19.5961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2039  -20.0060    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.9143  -19.6032    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.9184  -18.7860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.2121  -18.3716    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0989  -17.9617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.0989  -18.7789    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.8042  -19.1834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.5094  -17.9617    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.8042  -17.5490    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8042  -16.7318    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3900  -17.5552    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.6193  -20.0164    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3296  -19.6123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0347  -20.0255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0270  -20.8435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7313  -21.2566    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4426  -20.8525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.4452  -20.0311    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7404  -19.6217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3927  -19.1890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.6840  -18.7822    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7431  -18.8045    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  1  0
  7 11  1  0
  8  9  1  0
  9  1  1  0
  1 10  1  0
 10 11  1  0
 11 12  1  1
  7 13  2  0
  4 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
  8 22  1  0
 22 23  1  0
 21 24  1  0
M  END

Associated Targets(Human)

ADRA1A Tclin Alpha-1a adrenergic receptor (8359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SIGMAR1 Tclin Sigma opioid receptor (6358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OPRM1 Tclin Mu opioid receptor (19785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 334.44Molecular Weight (Monoisotopic): 334.2057AlogP: 2.47#Rotatable Bonds: 4
Polar Surface Area: 32.78Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.39CX LogP: 2.10CX LogD: 1.08
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.85Np Likeness Score: -0.81

References

1. García M,Virgili M,Alonso M,Alegret C,Farran J,Fernández B,Bordas M,Pascual R,Burgueño J,Vidal-Torres A,Fernández de Henestrosa AR,Ayet E,Merlos M,Vela JM,Plata-Salamán CR,Almansa C.  (2020)  Discovery of EST73502, a Dual μ-Opioid Receptor Agonist and σ Receptor Antagonist Clinical Candidate for the Treatment of Pain.,  63  (24): [PMID:33064947] [10.1021/acs.jmedchem.0c01127]

Source